Abstract
Introduction: Hypokinetic dysarthria (HD) is a common motor speech symptom of Parkinson’s disease (PD) which does not respond well to PD treatments. We investigated short-term effects of transcranial direct current stimulation (tDCS) on HD in PD using acoustic analysis of speech. Based on our previous studies we focused on stimulation of the right superior temporal gyrus (STG) - an auditory feedback area. Methods: In 14 PD patients with HD, we applied anodal, cathodal and sham tDCS to the right STG using a cross-over design. A protocol consisting of speech tasks was performed prior to and immediately after each stimulation session. Linear mixed models were used for the evaluation of the effects of each stimulation condition on the relative change of acoustic parameters. We also performed a simulation of the mean electric field induced by tDCS. Results: Linear mixed model showed a statistically significant effect of the stimulation condition on the relative change of median duration of silences longer than 50 ms (p = 0.015). The relative change after the anodal stimulation (mean = -5.9) was significantly lower as compared to the relative change after the sham stimulation (mean = 12.8), p = 0.014. We also found a correlation between the mean electric field magnitude in the right STG and improvement of articulation precision after anodal tDCS (R = 0.637; p = 0.019). Conclusions: The exploratory study showed that anodal tDCS applied over the auditory feedback area may lead to shorter pauses in a speech of PD patients.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Approximately 90% of individuals with PD experience hypokinetic dysarthria (HD) as the disease progresses (Ramig et al. 2008). HD is defined by decreased variability in pitch and volume, imprecise articulation, impaired speech prosody, and inappropriate silences (Brabenec et al. 2017).
Studies examining the effect of dopaminergic medication on HD report mixed results (Brabenec et al. 2017). Most of the evidence suggests that levodopa has no significant short-term effects on speech (Skodda et al. 2010; Cavallieri et al. 2021). Longitudinal studies (Rusz et al. 2016; Tykalova et al. 2015) revealed that levodopa administration in the early stages of PD may improve consonant articulation but also lead to more dysfluent speech. A recent study (Rusz et al. 2021) found variable responses to long-term levodopa administration among early PD patients depending on specific HD phenotypes.
Speech findings after the deep brain stimulation (DBS) also vary (Skodda et al. 2014; Baudouin et al. 2023). Previous research showed that DBS may improve voice tremor or voice intensity (Tripoliti et al. 2011; Tsuboi et al. 2014), but at the same time, it may worsen speech intelligibility (Tripoliti et al. 2011, 2014; Pinto et al. 2014; Tsuboi et al. 2014). Predictive factors of this deterioration include longer disease duration and lower speech intelligibility before surgery (Tripoliti et al. 2014; Pinto et al. 2023). Taken together, the effects of pharmacological and surgical interventions on HD are limited and varied. Therefore, there is a need to explore other methods that target different aspects of speech and could potentially be used also in later stages of PD.
We focused our research on non-invasive brain stimulation methods (NIBS). In PD patients with HD, repetitive transcranial magnetic stimulation (rTMS) has been mostly applied over a primary orofacial area (OFSM1) with inconsistent results (Brabenec et al. 2017). However, previous research showed that particularly the right posterior superior temporal gyrus (STG), a cortical region involved in auditory speech feedback (Liu et al. 2023), plays an important role in modulation of motor aspects of speech production in PD patients (New et al. 2015; Klobusiakova et al. 2021). In our previous study (Brabenec et al. 2019), we demonstrated that a single session of 1 HZ rTMS over the right STG may lead to significant improvement of articulation in PD. The improvements were significantly higher than improvements after 10 Hz stimulation over the left OFSM1, and more pronounced than the stimulation of a control stimulation site (Brabenec et al. 2019). A subsequent study also showed that multiple sessions of active rTMS over the right STG, as compared to sham stimulation, had long-lasting positive effects on HD, particularly on perceptual measures of articulation, prosody, and speech intelligibility. These effects were supported by remote stimulation-induced brain plasticity changes within the articulatory networks (Brabenec et al. 2021).
In our current project, we aim to develop a program for remote treatment of HD. To achieve our goal, we chose transcranial direct current stimulation (tDCS) that can be used remotely by patients at home together with a concurrent Lee Silverman Voice Treatment (LSVT), i.e., the best documented therapy for symptoms of HD in PD (Yuan et al. 2020). In PD patients, tDCS and other modes of temporal electrical stimulation (tES) have mostly been used to modulate gait speed, freezing of gait, limb bradykinesia, attention and executive functions, and brain excitability (Ni et al. 2022). Studies also provided evidence that home-based tDCS treatment is feasible and safe for PD patients (Dobbs et al. 2018). To our knowledge, research on the effects of tDCS/ tES on HD symptoms in PD has not yet been conducted.
In this pilot study, we particularly concentrated on identifying a suitable electrode montage and examined immediate aftereffects of a single session of tDCS on HD symptoms. These acute effects could last up to an hour (Nitsche et al. 2008; Brunoni et al. 2012). Studies have also shown that different current flow directions may result in different aftereffects, and the direction of the excitability shift might be divergent, dependent not only on stimulation polarity, but also on the specific electrode montage (Nitsche et al. 2008). Therefore, we applied both anodal and cathodal tDCS to the right STG. We also used SimNIBS (Thielscher et al. 2015) software for simulation of the mean electric field induced by tDCS. Regarding behavioral outcomes, we focused on the acoustic parameters that were responsive to non-invasive brain stimulation methods in our previous studies (Brabenec et al. 2017, 2019).
Methods
Participants
The inclusion criteria for enrolment into the study were as follows: (1) clinically established PD (criteria by Postuma et al. 2016), (2) right-handedness, (3) presence of HD symptoms based on the assessment of a speech therapist and the results of a 3F Test Dysarthric profile total score (Kostalova 2013), (4) Czech as their first language. Exclusion criteria were (1) alcohol or drug abuse, (2) hallucinations, (3) any diagnosed psychiatric disorder (4) dementia, based on the Montreal Cognitive Assessment (MoCA) test for dementia, MoCA > 20 (Biundo et al. 2014), and on a clinician’s interview with a caregiver (5) cardio pacemaker or any MRI-incompatible metal in the body, (6) epilepsy.
The disease severity was assessed using the Unified Parkinson’s Disease Rating Scale (UPDRS), part III (Motor Examination) scale. All participants were on a stable dopaminergic medication at least 4 weeks prior to baseline assessment and during the whole study. The patients were tested in the ON medication state without dyskinesias since we wanted to modulate HD symptoms in a real-life scenario in patients on dopaminergic medication. All patients signed an informed consent form that was approved by the local ethics committee.
Study design
Participants underwent tDCS over the right posterior STG. At the baseline visit, each participant underwent a speech assessment using the 3F Test Dysarthric profile (Kostalova 2013) (for details see Table S1 in Supplementary materials). Structural MRI scans (T1 MPRAGE) were performed for frameless stereotactic navigation of the electrode placement. After the baseline visit, each participant underwent three stimulation sessions (anodal, cathodal, and sham stimulation), separated by one day without stimulation. A crossover double-blind design was used, and stimulation protocols were randomized across subjects and sessions.
A protocol consisting of speech tasks lasted up to 10 min and was performed prior to and immediately after each stimulation session.
Acoustic analysis of speech
The speech protocol contained a special reading task (reading a phonetically balanced paragraph containing 150 words; patients were allowed read the text in advance). HD symptoms were assessed using speech parameters of interest based on our previous research.(Brabenec et al. 2019) More specifically, we quantified tongue and jaw rigidity (relF1SD and relF2SD), monopitch (relF0SD), duration of silences (DurMED), and irregular speech rhythms (SPIR) (see Table 1 for detailed description of the parameters).
TDCS protocol
Stimulation was applied through a battery-driven device (DC-Stimulator Plus, neuroConn GmbH, Germany). Both electrodes were positioned over the right and left posterior superior temporal gyrus (STG) (MNI coordinates: X = 40, Y = − 38, Z = 14; X = − 40, Y = − 38, Z = 14; based on our previous research) (Brabenec et al. 2021). We used the T1 MRI scan-based frameless stereotactic neuronavigation to specify the exact location of the electrode center in each individual. For anodal stimulation, the anode was placed over the right STG and the cathode over the left STG. For cathodal stimulation, the cathode was placed over the right STG and the anode over the left STG.
A current of 2 mA was delivered using two rubber electrodes (5 × 5 cm) for 20 min. The electrode was held in place by a conductive gel. The sham stimulation was applied with the same settings, but the stimulator was turned off after 30 s.
Statistical analysis
We used linear mixed models (LMM) to evaluate the effects of each stimulation condition on the relative changes in acoustic parameters. The stimulation condition was a fixed factor in LMM. Post-hoc pairwise comparisons of estimated marginal means were made with the Bonferroni correction. Age, gender, and levodopa equivalent dose (LED) were used as covariates in all LMMs. Wilcoxon signed-rank tests were used to compare the values of these parameters prior to and after each stimulation condition. A Spearman correlation analysis was used to assess associations between the tDCS-induced changes and the simulation of the electric field in right STG. These statistical procedures were performed with IBM SPSS Version 25.0 (IBM Corp., Armonk, NY, USA).
Electric field simulation in SimNIBS
SimNIBS software (version 4.0.1) was used to calculate the electric field induced by tDCS, based on the finite element method and individualized tetrahedral head meshes generated from the structural T1 images of the participant. Electric field simulations were computed for both cathodal and anodal montages. Both electrodes were positioned based on the MNI coordinates mentioned previously. The mean electric field in the right STG (sphere radius = 10 mm) was calculated using a MATLAB script.
Results
We enrolled 14 right-handed patients with clinically established PD. All had mild to moderate HD based on the assessment of a speech therapist and the results of a 3F Test Dysarthric total score (Kostalova 2013). The maximum total score is 90 (normal speech), and the minimum score is 0. See Table 2 for demographic and clinical data.
Using linear mixed model analysis (LMM) (see Table 3), we observed a significant effect of the stimulation condition on changes in the median duration of silences longer than 50 ms (F(2,21.8) = 5.1, p = 0.015), i.e. inappropriate silences that negatively impact speech rhythm and speech fluency (Brabenec et al. 2017). The relative decreases in long pauses after anodal stimulation (mean = -5.9) were significantly higher than the changes after the sham stimulation (mean = 12.8), p = 0.014, and non-significantly higher than the changes induced by the cathodal stimulation (mean = -0.5), p = 0.111 (see Fig. 1). Results of Post-hoc Wilcoxon test showed that anodal stimulation induced a significant decrease of this parameter (p = 0.047) (see Table 4).
Electric field simulation, as assessed by SimNIBS, (Thielscher et al. 2015) indicated a significant correlation between the mean electric field in the right STG and relative changes in the standard deviation of the second formant after anodal tDCS (R = 0.637; p = 0.019) (see Table 5 and Fig. 2). This parameter describes the tongue and jaw movements, and it is used for evaluating articulation precision (Brabenec et al. 2017). However, this parameter did not significantly change due to the stimulation.
Discussion
This exploratory cross-over randomized study found that anodal tDCS targeting the auditory feedback area in the right hemisphere can significantly improve motor speech fluency in PD patients. Moreover, the electric field in this region was positively correlated with anodal tDCS-induced changes in articulation precision.
These results are in partial accord with the results of our rTMS study in which low-frequency stimulation was used. Notably, rTMS-induced BOLD signal increases of the right STG were associated with changes of the same articulation parameter as in the current study (Brabenec et al. 2019). Therefore, it seems plausible that both stimulation protocols may lead to similar neural changes, but unlike in our rTMS study the effect of anodal tDCS alone was probably too weak to translate into significant behavioral improvements in articulation. Improved motor speech fluency was not identified in our single session rTMS study; however, there was a trend for improved speech rhythmicity; in other words, both stimulation protocols positively modulated temporal aspects of motor speech output. It has to be pointed out that different tasks were used in the two studies: reading of simple sentences in the rTMS study and reading of the whole paragraph in the current study.
This study has several limitations. We used the same MNI coordinates for all participants and did not implement individualized stimulation. However, it is important to note that tDCS stimulation is inherently less focal, and this pilot study served as a preparation for home-based stimulation, where achieving precise individualization is not practically feasible. Our sample size was determined based on the immediate medium aftereffects observed in a single session of rTMS (Brabenec et al. 2019), but the effects of tDCS could be much weaker. Nevertheless, we observed significant effect of tDCS on speech.
The main difference between the effects of rTMS and tDCS is that rTMS can trigger an action potential and tDCS can only modulate resting membrane potential and change the probability of the action potential occurrence (Nitsche et al. 2008). Thus, tDCS affects active neurons and is usually combined with behavioral training for more pronounced and long-term effects (Ni et al. 2022). In clinical practice, the gold standard for treatment of HD is currently the LSVT (Yuan et al. 2020). This high-effort speech therapy is primarily focused on improving speech loudness; previous studies showed that LSVT also increased the activation of the right STG and these changes correlated with improved speech intelligibility (Baumann et al. 2018).
Therefore, in a future study, we will investigate long-term behavioral effects and brain plasticity changes due to the home-based long-term tDCS as an add-on treatment to remote LSVT, delivered via telepractice.
Data availability
The data that support the findings of this study are available from the corresponding author upon reasonable request.
References
Baudouin R, Lechien JR, Carpentier L et al (2023) Deep brain stimulation impact on Voice and Speech Quality in Parkinson’s Disease: a systematic review. Otolaryngology–Head Neck Surg 168:307–318. https://doi.org/10.1177/01945998221120189
Baumann A, Nebel A, Granert O et al (2018) Neural correlates of Hypokinetic Dysarthria and mechanisms of effective Voice treatment in Parkinson Disease. Neurorehabil Neural Repair 32:1055–1066. https://doi.org/10.1177/1545968318812726
Biundo R, Weis L, Facchini S et al (2014) Cognitive profiling of Parkinson disease patients with mild cognitive impairment and dementia. Parkinsonism Relat Disord 20:394–399. https://doi.org/10.1016/J.PARKRELDIS.2014.01.009
Brabenec L, Mekyska J, Galaz Z, Rektorova I (2017) Speech disorders in Parkinson’s disease: early diagnostics and effects of medication and brain stimulation. J Neural Transm 124:303–334. https://doi.org/10.1007/s00702-017-1676-0
Brabenec L, Klobusiakova P, Barton M et al (2019) Non-invasive stimulation of the auditory feedback area for improved articulation in Parkinson’s disease. Parkinsonism Relat Disord 61:187–192. https://doi.org/10.1016/j.parkreldis.2018.10.011
Brabenec L, Klobusiakova P, Simko P et al (2021) Non-invasive brain stimulation for speech in Parkinson’s disease: a randomized controlled trial. Brain Stimul 14:571–578. https://doi.org/10.1016/J.BRS.2021.03.010
Brunoni AR, Nitsche MA, Bolognini N et al (2012) Clinical research with transcranial direct current stimulation (tDCS): challenges and future directions. Brain Stimul 5:175–195
Cavallieri F, Budriesi C, Gessani A et al (2021) Dopaminergic treatment effects on Dysarthric Speech: acoustic analysis in a cohort of patients with Advanced Parkinson’s Disease. Front Neurol 11. https://doi.org/10.3389/FNEUR.2020.616062/FULL
Dobbs B, Pawlak N, Biagioni M et al (2018) Generalizing remotely supervised transcranial direct current stimulation (tDCS): feasibility and benefit in Parkinson’s disease. J Neuroeng Rehabil 15. https://doi.org/10.1186/S12984-018-0457-9
Klobusiakova P, Mekyska J, Brabenec L et al (2021) Articulatory network reorganization in Parkinson’s disease as assessed by multimodal MRI and acoustic measures. Parkinsonism Relat Disord 84:122–128. https://doi.org/10.1016/j.parkreldis.2021.02.012
Kostalova M (2013) Test 3F Dysartrický profil – normativní hodnoty řeči v češtině. Cesk Slov Neurol N 614–618
Liu D, Chang Y, Dai G et al (2023) Right, but not left, posterior superior temporal gyrus is causally involved in vocal feedback control. NeuroImage 278:120282. https://doi.org/10.1016/J.NEUROIMAGE.2023.120282
New AB, Robin Da, Parkinson AL et al (2015) The intrinsic resting state voice network in Parkinson’s disease. Hum Brain Mapp 36:1951–1962. https://doi.org/10.1002/hbm.22748
Ni R, Yuan Y, Yang L et al (2022) Novel non-invasive transcranial electrical stimulation for Parkinson’s Disease. Front Aging Neurosci 14. https://doi.org/10.3389/FNAGI.2022.880897/FULL
Nitsche MA, Cohen LG, Wassermann EM et al (2008) Transcranial direct current stimulation: state of the art 2008. Brain Stimul 1:206–223. https://doi.org/10.1016/j.brs.2008.06.004
Pinto S, Ferraye M, Espesser R et al (2014) Stimulation of the pedunculopontine nucleus area in Parkinson’s disease: effects on speech and intelligibility. Brain 137:2759–2772. https://doi.org/10.1093/brain/awu209
Pinto S, Nebel A, Rau J et al (2023) Results of a Randomized Clinical Trial of Speech after Early Neurostimulation in Parkinson’s Disease. Mov Disord 38:212–222. https://doi.org/10.1002/MDS.29282
Postuma RB, Berg D, Adler CH et al (2016) The new definition and diagnostic criteria of Parkinson’s disease. Lancet Neurol 15:546–548. https://doi.org/10.1016/S1474-4422(16)00116-2
Ramig LO, Fox C, Sapir S (2008) Speech treatment for Parkinson’s disease. Expert Rev Neurother 8:297–309. https://doi.org/10.1586/14737175.8.2.297
Rusz J, Tykalová T, Klempíř J et al (2016) Effects of dopaminergic replacement therapy on motor speech disorders in Parkinson’s disease: longitudinal follow-up study on previously untreated patients. J Neural Transm (Vienna) 123:379–387. https://doi.org/10.1007/s00702-016-1515-8
Rusz J, Tykalova T, Novotny M et al (2021) Defining Speech subtypes in De Novo Parkinson Disease: response to long-term levodopa therapy. Neurology 97:e2124–e2135. https://doi.org/10.1212/WNL.0000000000012878
Skodda S, Visser W, Schlegel U (2010) Short- and long-term dopaminergic effects on dysarthria in early Parkinson’s disease. J Neural Transm 117:197–205. https://doi.org/10.1007/s00702-009-0351-5
Skodda S, Grönheit W, Schlegel U et al (2014) Effect of subthalamic stimulation on voice and speech in Parkinson’s disease: for the better or worse? Front Neurol 4:1–9. https://doi.org/10.3389/fneur.2013.00218
Thielscher A, Antunes A, Saturnino GB Field modeling for transcranial magnetic stimulation: A useful tool to understand the physiological effects of TMS? In: 2015 37th Annual International Conference of the IEEE Engineering in Medicine and Biology, Society (2015) (EMBC). IEEE, pp 222–225
Tripoliti E, Zrinzo L, Martinez-Torres I et al (2011) Effects of subthalamic stimulation on speech of consecutive patients with Parkinson disease. Neurology 76:80–86. https://doi.org/10.1212/WNL.0b013e318203e7d0
Tripoliti E, Limousin P, Foltynie T et al (2014) Predictive factors of speech intelligibility following subthalamic nucleus stimulation in consecutive patients with Parkinson’s disease. Mov Disord 29:532–538. https://doi.org/10.1002/mds.25816
Tsuboi T, Watanabe H, Tanaka Y et al (2014) Distinct phenotypes of speech and voice disorders in Parkinson’s disease after subthalamic nucleus deep brain stimulation. J Neurol Neurosurg Psychiatry 86:1–9. https://doi.org/10.1136/jnnp-2014-308043
Tykalova T, Rusz J, Cmejla R et al (2015) Effect of dopaminergic medication on speech dysfluency in Parkinson’s disease: a longitudinal study. J Neural Transm (Vienna) 122:1135–1142. https://doi.org/10.1007/s00702-015-1363-y
Yuan F, Guo X, Wei X et al (2020) Lee Silverman Voice Treatment for Dysarthria in patients with Parkinson’s disease: a systematic review and meta-analysis. Eur J Neurol 2020:1957–1970. https://doi.org/10.1111/ene.14399
Acknowledgements
This project received funding from the Czech Ministry of Health, grant NU22J-04-00074 and from project nr.LX22NPO5107(MEYS): Funded by European Union – Next Generation EU. We also acknowledge the core facility MAFIL supported by MEYS CR (LM2023050 Czech-BioImaging), part of the Euro-BioImaging (https://www.eurobioimaging.eu/) ALM and Medical Imaging Node (Brno, CZ).
Funding
Open access publishing supported by the National Technical Library in Prague. This project received funding from the Czech Ministry of Health, grant NU22J-04-00074 and from project nr.LX22NPO5107(MEYS): Funded by European Union – Next Generation EU.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
None.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Brabenec, L., Kovac, D., Mekyska, J. et al. Short-term effects of transcranial direct current stimulation on motor speech in Parkinson’s disease: a pilot study. J Neural Transm 131, 791–797 (2024). https://doi.org/10.1007/s00702-024-02771-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-024-02771-5